Coldstream Capital Management Inc Sarepta Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q4 2024
A detailed history of Coldstream Capital Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,654 shares of SRPT stock, worth $176,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,654Holding current value
$176,895% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.1 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$972 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$930 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$463 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$435 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.37B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...